PIONEER: Bayesian Joint Modelling of Mechanistic Tumour Growth and Time-to-Event Endpoints for Dynamic Prediction of Ongoing Oncology Trials

Karim Naguib, Roger Berché, Lu Li +4

High-stakes decisions in oncology clinical trials must often be made while survival data remains immature: progression-free survival (PFS) and overall survival (OS) are heavily cen…